instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Hyperkalaemia'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 19,725,787 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 19,725,787 | 2021 |
What was the outcome of reaction 'Muscle strength abnormal'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Muscular weakness'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Myalgia'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Mycobacterium chelonae infection'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Myopathy'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovering | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Nausea'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Oedema peripheral'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Off label use'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 19,625,908 | 2021 |
What was the outcome of reaction 'Quadriparesis'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Renal disorder'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 19,725,787 | 2021 |
What was the outcome of reaction 'Rhabdomyolysis'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
What was the outcome of reaction 'Skin bacterial infection'? | When Should Statins Be Stopped?
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromyc... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34268273 | 17,130,694 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular block first degree'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,656,276 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram ST segment depression'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,656,276 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | AMIODARONE, MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,948,899 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'QRS axis abnormal'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus rhythm'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stress cardiomyopathy'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,656,276 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular fibrillation'. | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | MISOPROSTOL | DrugsGivenReaction | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
What was the administration route of drug 'MISOPROSTOL'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34268275 | 19,656,276 | 2021 |
What was the outcome of reaction 'Arteriospasm coronary'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268275 | 19,656,276 | 2021 |
What was the outcome of reaction 'Atrioventricular block first degree'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
What was the outcome of reaction 'Electrocardiogram ST segment depression'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
What was the outcome of reaction 'QRS axis abnormal'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
What was the outcome of reaction 'Sinus rhythm'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
What was the outcome of reaction 'Ventricular fibrillation'? | Misoprostol-induced Coronary Vasospasm Complicated by Takotsubo Cardiomyopathy and Cardiac Arrest.
Misoprostol is a synthetic E1 prostaglandin commonly used to induce abortion in the United States and elsewhere. There is limited literature on the cardiovascular adverse effects of misoprostol, and, to the best of our kn... | Recovered | ReactionOutcome | CC BY-NC-ND | 34268275 | 19,941,342 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | ENOXAPARIN, HYDROXYCHLOROQUINE, INSULIN NOS | DrugsGivenReaction | CC BY | 34268280 | 19,967,473 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | ENOXAPARIN, HYDROXYCHLOROQUINE, INSULIN NOS | DrugsGivenReaction | CC BY | 34268280 | 19,967,473 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory distress'. | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE, INSULIN NOS | DrugsGivenReaction | CC BY | 34268280 | 19,967,060 | 2021 |
What was the administration route of drug 'ENOXAPARIN SODIUM'? | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | Transplacental | DrugAdministrationRoute | CC BY | 34268280 | 19,967,060 | 2021 |
What was the administration route of drug 'ENOXAPARIN'? | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | Transplacental | DrugAdministrationRoute | CC BY | 34268280 | 20,017,556 | 2021 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | Transplacental | DrugAdministrationRoute | CC BY | 34268280 | 20,017,556 | 2021 |
What was the administration route of drug 'INSULIN NOS'? | Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an Infant With X-Linked Recessive Mendelian Susceptibility to Mycobacterial Disease Due to a Variant of Chronic Granulomatous Disease.
In the United Arab Emirates, BCG (Bacillus Calmette-Guérin) is administered to all newborns. We present here a young inf... | Transplacental | DrugAdministrationRoute | CC BY | 34268280 | 20,017,556 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal distension'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Biliary tract infection'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic encephalopathy'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jaundice cholestatic'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to adrenals'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to liver'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | AFATINIB | DrugsGivenReaction | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
What was the administration route of drug 'AFATINIB'? | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
What was the dosage of drug 'AFATINIB'? | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | 40 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
What was the outcome of reaction 'Biliary tract infection'? | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | Fatal | ReactionOutcome | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
What was the outcome of reaction 'Hepatic encephalopathy'? | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | Fatal | ReactionOutcome | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
What was the outcome of reaction 'Jaundice cholestatic'? | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | Fatal | ReactionOutcome | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
What was the outcome of reaction 'Pneumonia'? | Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.
Despite concerted efforts that have been made to characterize and understand the genomic landscape of gastric cancer (GC), only HER2 has been validated as a molecular target for G... | Fatal | ReactionOutcome | CC BY-NC-ND | 34268427 | 19,391,967 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | The effect of transcatheter aortic valve implantation on pulmonary artery pressures in a patient suffering from chronic heart failure: a case report.
Pulmonary hypertension (PH) is most commonly caused by left-sided heart disease and may negatively affect the long-term prognosis and quality of life of patients with chr... | BUMETANIDE, EPLERENONE, SACUBITRIL\VALSARTAN, SILDENAFIL | DrugsGivenReaction | CC BY-NC | 34268473 | 19,770,153 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | The effect of transcatheter aortic valve implantation on pulmonary artery pressures in a patient suffering from chronic heart failure: a case report.
Pulmonary hypertension (PH) is most commonly caused by left-sided heart disease and may negatively affect the long-term prognosis and quality of life of patients with chr... | BUMETANIDE, EPLERENONE, SACUBITRIL\VALSARTAN, SILDENAFIL | DrugsGivenReaction | CC BY-NC | 34268473 | 19,770,153 | 2021-04 |
What was the dosage of drug 'BUMETANIDE'? | The effect of transcatheter aortic valve implantation on pulmonary artery pressures in a patient suffering from chronic heart failure: a case report.
Pulmonary hypertension (PH) is most commonly caused by left-sided heart disease and may negatively affect the long-term prognosis and quality of life of patients with chr... | 7.5 MILLIGRAM, QD, MAXIMUM TOLERATED DAILY DOSE | DrugDosageText | CC BY-NC | 34268473 | 19,770,153 | 2021-04 |
What was the dosage of drug 'EPLERENONE'? | The effect of transcatheter aortic valve implantation on pulmonary artery pressures in a patient suffering from chronic heart failure: a case report.
Pulmonary hypertension (PH) is most commonly caused by left-sided heart disease and may negatively affect the long-term prognosis and quality of life of patients with chr... | 50 MILLIGRAM, QD | DrugDosageText | CC BY-NC | 34268473 | 19,770,153 | 2021-04 |
What was the dosage of drug 'SACUBITRIL\VALSARTAN'? | The effect of transcatheter aortic valve implantation on pulmonary artery pressures in a patient suffering from chronic heart failure: a case report.
Pulmonary hypertension (PH) is most commonly caused by left-sided heart disease and may negatively affect the long-term prognosis and quality of life of patients with chr... | 1 DOSAGE FORM, QD, AT A MAXIMUM TOLERATED DAILY DOSE | DrugDosageText | CC BY-NC | 34268473 | 19,770,153 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report.
Coronavirus Disease-2019 (COVID-19) has been associated with increased incidence of pulmonary embolism (PE), even among patients at low risk for venous thrombo-embolic (VTE) events.
We present th... | EPINEPHRINE, HEPARIN SODIUM, NOREPINEPHRINE, PHENYLEPHRINE HYDROCHLORIDE, VASOPRESSIN | DrugsGivenReaction | CC BY-NC | 34268475 | 19,873,184 | 2021-04 |
What was the administration route of drug 'HEPARIN SODIUM'? | Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report.
Coronavirus Disease-2019 (COVID-19) has been associated with increased incidence of pulmonary embolism (PE), even among patients at low risk for venous thrombo-embolic (VTE) events.
We present th... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34268475 | 19,873,184 | 2021-04 |
What was the dosage of drug 'HEPARIN SODIUM'? | Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report.
Coronavirus Disease-2019 (COVID-19) has been associated with increased incidence of pulmonary embolism (PE), even among patients at low risk for venous thrombo-embolic (VTE) events.
We present th... | INTRAVENOUS INFUSION | DrugDosageText | CC BY-NC | 34268475 | 19,873,184 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.
Sitosterolaemia is a rare, autosomal recessive dyslipidaemia with increased absorption of dietary plant sterol and often presents with hypercholesterolaemia, xanthomas, and haematologic manifestations. If left unt... | ATORVASTATIN CALCIUM, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 34268478 | 19,754,437 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effect less than expected'. | Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.
Sitosterolaemia is a rare, autosomal recessive dyslipidaemia with increased absorption of dietary plant sterol and often presents with hypercholesterolaemia, xanthomas, and haematologic manifestations. If left unt... | ATORVASTATIN CALCIUM, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 34268478 | 19,754,437 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.
Sitosterolaemia is a rare, autosomal recessive dyslipidaemia with increased absorption of dietary plant sterol and often presents with hypercholesterolaemia, xanthomas, and haematologic manifestations. If left unt... | ATORVASTATIN CALCIUM, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 34268478 | 19,754,437 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.
Sitosterolaemia is a rare, autosomal recessive dyslipidaemia with increased absorption of dietary plant sterol and often presents with hypercholesterolaemia, xanthomas, and haematologic manifestations. If left unt... | ATORVASTATIN CALCIUM, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 34268478 | 19,754,437 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.
Sitosterolaemia is a rare, autosomal recessive dyslipidaemia with increased absorption of dietary plant sterol and often presents with hypercholesterolaemia, xanthomas, and haematologic manifestations. If left unt... | ATORVASTATIN CALCIUM, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 34268478 | 19,754,437 | 2021-05 |
What was the outcome of reaction 'Acute hepatic failure'? | Seventeen years of misdiagnosis in rare dyslipidaemia: a case report of sitosterolaemia in a young female.
Sitosterolaemia is a rare, autosomal recessive dyslipidaemia with increased absorption of dietary plant sterol and often presents with hypercholesterolaemia, xanthomas, and haematologic manifestations. If left unt... | Recovered | ReactionOutcome | CC BY-NC | 34268478 | 19,775,846 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Partial seizures'. | Late diagnoses of Dravet syndrome: How many individuals are we missing?
We report new genetic diagnoses of Dravet syndrome in a group of adults with complex epilepsy of unknown cause, under follow-up at a tertiary epilepsy center. Individuals with epilepsy and other features of unknown cause from our unit underwent who... | CLOBAZAM, VALPROIC ACID, ZONISAMIDE | DrugsGivenReaction | CC BY | 34268891 | 20,729,075 | 2021-12 |
What was the dosage of drug 'CLONAZEPAM'? | Late diagnoses of Dravet syndrome: How many individuals are we missing?
We report new genetic diagnoses of Dravet syndrome in a group of adults with complex epilepsy of unknown cause, under follow-up at a tertiary epilepsy center. Individuals with epilepsy and other features of unknown cause from our unit underwent who... | UNK, 2 | DrugDosageText | CC BY | 34268891 | 20,709,343 | 2021-12 |
What was the dosage of drug 'LACOSAMIDE'? | Late diagnoses of Dravet syndrome: How many individuals are we missing?
We report new genetic diagnoses of Dravet syndrome in a group of adults with complex epilepsy of unknown cause, under follow-up at a tertiary epilepsy center. Individuals with epilepsy and other features of unknown cause from our unit underwent who... | UNK, 350 | DrugDosageText | CC BY | 34268891 | 20,709,343 | 2021-12 |
What was the dosage of drug 'PRIMIDONE'? | Late diagnoses of Dravet syndrome: How many individuals are we missing?
We report new genetic diagnoses of Dravet syndrome in a group of adults with complex epilepsy of unknown cause, under follow-up at a tertiary epilepsy center. Individuals with epilepsy and other features of unknown cause from our unit underwent who... | 625 | DrugDosageText | CC BY | 34268891 | 20,729,693 | 2021-12 |
What was the dosage of drug 'TOPIRAMATE'? | Late diagnoses of Dravet syndrome: How many individuals are we missing?
We report new genetic diagnoses of Dravet syndrome in a group of adults with complex epilepsy of unknown cause, under follow-up at a tertiary epilepsy center. Individuals with epilepsy and other features of unknown cause from our unit underwent who... | UNK, 500 | DrugDosageText | CC BY | 34268891 | 20,721,533 | 2021-12 |
What was the dosage of drug 'ZONISAMIDE'? | Late diagnoses of Dravet syndrome: How many individuals are we missing?
We report new genetic diagnoses of Dravet syndrome in a group of adults with complex epilepsy of unknown cause, under follow-up at a tertiary epilepsy center. Individuals with epilepsy and other features of unknown cause from our unit underwent who... | 100 | DrugDosageText | CC BY | 34268891 | 20,729,075 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory distress syndrome'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary hypertension'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachypnoea'. | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | FUROSEMIDE, MACITENTAN, SPIRONOLACTONE, TADALAFIL, TREPROSTINIL | DrugsGivenReaction | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the administration route of drug 'TREPROSTINIL'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the dosage of drug 'FUROSEMIDE'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | 20 MG, BID (DAILY) | DrugDosageText | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the dosage of drug 'MACITENTAN'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | 10 MG, DAILY | DrugDosageText | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the dosage of drug 'SPIRONOLACTONE'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | 25 MG DAILY | DrugDosageText | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the dosage of drug 'TADALAFIL'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | 20 MG, DAILY | DrugDosageText | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the dosage of drug 'TREPROSTINIL'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | 0.045 ?G/KG, CONTINUING | DrugDosageText | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Chest pain'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Dyspnoea'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Fatigue'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Oedema peripheral'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Pleural effusion'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Pulmonary hypertension'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Tachycardia'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
What was the outcome of reaction 'Tachypnoea'? | An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
Pulmonary hypertension (PH) is often a difficult condition to diagnose, since it occurs insidiously and is a diagnosis of exclusion. Patients with neurofibromatosis type 1 (NFT1) have been associated with severe exa... | Recovering | ReactionOutcome | CC BY-NC | 34269074 | 19,921,687 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Comparison of efficacy of two different doses of tranexamic acid in prevention of post operative blood loss in patients with congenital cyanotic heart disease undergoing cardiac surgery.
The optimal dose of tranexamic acid in minimizing perioperative bleeding is uncertain. We compared efficacy of two different doses of... | TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC-SA | 34269265 | 19,686,447 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.